Open AccessThe role of interferon in the treatment of acute hepatitis C
Author(s) -
Jasmina Simonović-Babić,
Dragan Delić,
Neda Švirtlih
Publication year - 2007
Publication title -
medicinski pregled
Language(s) - English
Resource type - Journals
eISSN - 1820-7383
pISSN - 0025-8105
DOI - 10.2298/mpns0708322s
Subject(s) - medicine , ribavirin , hepatology , interferon , gastroenterology , hepatitis c virus , alanine aminotransferase , immunology , bilirubin , liver disease , virus
Progression from acute to chronic HCV infection occurs in 50% to 84% of cases. Even the latest approach--combination therapy with pegilated interferon alfa 2-a or 2b and ribavirin--eliminates the virus in only 54% to 56% of cases with chronic infection. The aim of this study is to determine whether treatment during the acute phase prevents the development of chronic infection.